Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
ZVRA Quote, Financials, Valuation and Earnings
Last price:
$12.66
Seasonality move
:
11.56%
Day range:
$12.17 - $12.89
52-week range:
$5.45 - $13.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.97x
P/B ratio:
16.42x
Volume:
1.6M
Avg. volume:
1M
1-year change:
88.38%
Market cap:
$673.7M
Revenue:
$23.6M
EPS (TTM):
-$1.92
Earnings Data
Next earnings date for ZVRA
Aug 13
2025
Most recent earnings per share
-$0.06
Beat by $0.12
(May 13/2025)
Consensus Estimate
-$0.18
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $24.3M | -- | -- | -$0.07 | -- |
| 08/13/2025 | Q2 | $22.5M | -- | -- | $1.61 | -- |
| 05/13/2025 | Q1 | $17M | $20.4M | -$0.06 | -$0.18 | $0.12 |
| 03/11/2025 | Q4 | $8.9M | $12M | -$0.69 | -$0.40 | -$0.29 |
| 11/12/2024 | Q3 | $4.9M | $3.7M | -$0.69 | -$0.41 | -$0.28 |
| 08/13/2024 | Q2 | $4.4M | $4.4M | -$0.48 | -$0.44 | -$0.04 |
| 05/08/2024 | Q1 | $3.8M | $3.4M | -$0.40 | -$0.48 | $0.08 |
| 03/28/2024 | Q4 | $11.7M | $12.9M | -$0.54 | -$0.27 | -$0.27 |
| 11/07/2023 | Q3 | $3.4M | $2.9M | -$0.30 | -$0.30 | -$0.00 |
| 08/14/2023 | Q2 | $3M | $8.5M | -$0.08 | -$0.34 | $0.26 |
| 05/15/2023 | Q1 | -- | $3.2M | -$0.38 | -- | -- |
| 03/07/2023 | Q4 | -- | $2M | $0.16 | -- | -- |
| 11/09/2022 | Q3 | -- | $2.9M | -$0.19 | -- | -- |
| 06/30/2022 | Q2 | -- | $1.3M | -$0.70 | -- | -- |
| 03/31/2022 | Q1 | -- | $4M | -$0.05 | -- | -- |
| 12/31/2021 | Q4 | -- | $2.6M | $0.05 | -- | -- |
| 09/30/2021 | Q3 | -- | $2M | -$0.05 | -- | -- |
| 06/30/2021 | Q2 | -- | $12M | -$0.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $12.1M | -$2.49 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.4M | -$1.13 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.9M | -$0.68 | -- | -- |
| 06/30/2020 | Q2 | -- | $6.9M | $0.21 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.1M | -$1.92 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.4M | -$2.83 | -- | -- |
| 09/30/2019 | Q3 | -- | $11.5M | $0.96 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$5.28 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$7.36 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $2.88 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$15.04 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$14.56 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$28.32 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$11.52 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$10.88 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$7.04 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$17.76 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$10.88 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$14.72 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $9.28 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$3.20 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$10.24 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$10.88 | -- | -- |
Zevra Therapeutics Earnings Questions
-
How Much did Zevra Therapeutics Generate in Revenue Last Quarter?
Zevra Therapeutics reported $20.4M worth of top line sales in its most recent quarter.
-
Did Zevra Therapeutics Beat Earnings Last Quarter?
Zevra Therapeutics announced earnings per share of -$0.06 which represents a beat of analyst forecast a -$0.18 per share.
-
Is Zevra Therapeutics Profitable?
Zevra Therapeutics reported $19.1M that represents $0.35 per share over the last quarter.
-
What is the Analyst Consensus for Zevra Therapeutics EPS Next Year?
Zevra Therapeutics's earnings are forecast to decrease from -$2.28 per share to -$1.93 per share next year representing a decrease of -98.25%.
-
When is Zevra Therapeutics's Earnings Date?
Zevra Therapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
